Novel Tamoxifen Nanoformulations for Improving Breast Cancer Treatment: Old Wine in New Bottles

Breast cancer (BC) is one of the leading causes of death from cancer in women; second only to lung cancer. Tamoxifen (TAM) is a hydrophobic anticancer agent and a selective estrogen modulator (SERM), approved by the FDA for hormone therapy of BC. Despite having striking efficacy in BC therapy, conce...

Descripción completa

Detalles Bibliográficos
Autores principales: Day, Candace M., Hickey, Shane M., Song, Yunmei, Plush, Sally E., Garg, Sanjay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7179425/
https://www.ncbi.nlm.nih.gov/pubmed/32151063
http://dx.doi.org/10.3390/molecules25051182

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7179425/
https://www.ncbi.nlm.nih.gov/pubmed/32151063
http://dx.doi.org/10.3390/molecules25051182

Ejemplares similares